Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
Waldencast (NASDAQ: WALD) said it will release Fourth Quarter and Fiscal Year 2025 results on March 13, 2026 before U.S. market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Waldencast (NASDAQ: WALD) said it will release Fourth Quarter and Fiscal Year 2025 results on March 13, 2026 before U.S. market open. The company also said it will not host a conference call to discuss results due to its ongoing strategic review.
Details
News Market Reaction – WALD
On Mar 12, the first trading day after this news, WALD closed 3.95% below the previous close.
Data tracked by StockTitan Argus for the Mar 12 session.
Key Figures
- Earnings release date
- March 13, 2026
- Q4 and Fiscal Year 2025 results to be issued before U.S. market open
Previous Earnings Reports
-
Reported H1 net loss with large goodwill impairments and mixed brand trends.
-
Q1 2025 results with high margins, EBITDA, new credit facility, and 2025 guidance.
-
Strong Q4 and full‑year 2024 growth and EBITDA with positive brand performance.
-
Q3 2024 showed strong comparable revenue growth and margin expansion.
-
Q2 2024 delivered strong comparable growth and higher Adjusted EBITDA margin.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform announced that its Fourth Quarter and Fiscal Year 2025 earnings will be issued in a press release on March 13, 2026, prior to U.S. market open. The Company does not plan to host a conference call to discuss results given its ongoing strategic review.
About Waldencast plc
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.
Contacts
Investors
ICR
Allison Malkin
waldencastir@icrinc.com
Media
ICR
Brittany Fraser
Waldencast@icrinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.